Methadone: A Bibliography, 1929-1971, Part 1

References

• Abreu B.E., et al. Effects of amphetamine, dihydro-ergotamine and methadon on human cerebral blood flow and oxygen up-take. Fed. Proc. 1948; 7(1)201
   PubMedGoogle Scholar
• Adler T.K., Eisenbrandt L.L. The initial up-take of C14-labeled methadone by rat tissues. Proc. Soc. Exper. Biol & Med. 1949; 72: 347
   PubMedGoogle Scholar
• Akera T., Brody T.M. The addiction cycle to narcotics in the rat and its relation to catecholamines. Biochem. Pharmacol. 1968; 17: 675
   PubMed Web of Science ®Google Scholar
• Alksne H., et al. A follow-up study of treated adolescent narcotic users. unpublished report of the Columbia University School of Public Health and Administrative Medicine, New York 1959
   Google Scholar
• Alternatives to morphine. Brit. Med. J. 1966; 2(5521)1056
   Google Scholar
• Althaus J.R., et al. Identification of the drug Darvon and its metabolites in the urine of a comatose patient using a gas chromatograph-mass spectrometer-computer system. Experientia 1970; 26(7)714
   PubMedGoogle Scholar
• Angibeaud P., Buchel L., Levy J. Sur quelques phenomenes de synergie. I. Associations d'analgesiques et d'un spasmolytique considere comme leur analogue structural, (Some phenomena of synergism. 1. Association of an analgesic with a spasmolytic regarded as its structural analogue). C. R. Soc. Biol. (Paris) 1955; 149(34)258
   PubMedGoogle Scholar
• Antweiler H. Biological detection of amidone abuse. Klin. Wschr. 1954; 32(5-6)138–39
   PubMedGoogle Scholar
• Assouline G. Modifications et relations comportementales et electrocorticographiques provoquees chez le lapin par administration prolongee d'analgesiques morphiniques. Compt. Rend. Soc. Biol. 1966; 160(11)2171–76
   PubMedGoogle Scholar
• Atanackovic D., De Jongh D.K. Action of methadone on blood pressure regulating mechanisms. Arch. Internal. Pharmacodyn. et de Therap. 1950; 82(4)494–98
   PubMedGoogle Scholar
• Ausubel D.P. The Dole-Nyswander treatment of heroin addiction. J.A.M.A. 1966; 195(11)949–50
   PubMedGoogle Scholar
• Bachelor A.L., Elliott H.W. The action of methadon upon the respiration of rat diaphragm and liver and kidney cortex slices. Fed. Proc. 1948; 7: 203
   PubMedGoogle Scholar
• Batterman R.C. The importance of addiction to the newer synthetic analgesics in human therapy. Ann. New York Acad. Sci. 1948; 51(1)123–29
   PubMedGoogle Scholar
• Batterman R.C., Oshlag A.M. The effectiveness and toxicity of methadon, a new analgesic agent. Anesthesiology 1949; 10(2)214–22
   PubMedGoogle Scholar
• Bauer G., Ziegler E., Konzett H. Zur Hemmwirkung von Kininen an isolierten Darmpraeparaten. Arch. Pharmakol. Exper. Pathol. 1966; 254(3)235–44
   Google Scholar
• Beaver W.T., et al. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin. Pharmacol. Therap. 1967; 8(3)415–26
   PubMedGoogle Scholar
• Beckett A.H. The importance of steric, stereochemical and physico-organic features in drug metabolism and drug action. Pure Appl. Chem. 1969; 19: 231–48
   PubMedGoogle Scholar
• Beckett A.H., Casy A.F. Stereochemistry of certain analgesics. Nature 1954; 173(1447)1231–32
   PubMedGoogle Scholar
• Beckett A.H., Moffat A.C. Routine detection and identification in urine of stimulants, analgesics, antihistamines, local anaesthetics and other drugs, some of which may be used to modify performance in sport. J. Pharm. Pharmacol. 1968; 20(12)48–50
   PubMedGoogle Scholar
• Beckett A.H., et al. The biotransformation of methadone in man: Synthesis and identification of a major metabolite. J Pharm. Pharmacol. 1968; 20(10)754–62
   PubMedGoogle Scholar
• Beecher H.K., et al. Field use of methadone and levo-iso-methadone in a combat zone. U.S. Armed Forces Med. J. 1951; 2(9)1269–76
   PubMedGoogle Scholar
• Begany A.J., Seifter J. Studies on a heparin-like compound, algarin. Fed. Proc. 1948; 7: 206
   PubMedGoogle Scholar
• Beleslin D.B., Bogdanovic S.B., Rakic M.M. Mechanism and site of action of methadone on the peristaltic reflex of the isolated guinea-pig ileum. Arch. Intern. Pharmacodyn. 1966; 164(2)345–55
   Google Scholar
• Bentley K.W., Bower J.D., Lewis J.W. Novel analgesics and molecular rearrangements in the morphine-thebaine group. Part XVI. Some derivatives of 6, 14-endo-theno-7, 8-dihydromorphine. J. Chem. Soc. 1969; 18C: 2569–72
   Google Scholar
• Berger H. Treatment of narcotic addicts in private practice. Arch. Intern. Med. 1964; 114: 59
   PubMedGoogle Scholar
• Bewley T.H. The diagnosis and management of heroin addiction. Practitioner 1968; 200(1196)215–19
   PubMedGoogle Scholar
• Bewley T.H., Ben Arie O. Physical dependence on heroin and pentobarbitone regimen for withdrawal. Practitioner 1968; 200(1196)251–53
   PubMedGoogle Scholar
• Bleter R.N., Hirsh S.A. Methadone in internal medicine. Ann. New York Acad. Sci. 1948; 51: 137
   PubMedGoogle Scholar
• Blachly P.H. Management of the opiate abstinence syndrome. Amer. J. Psychiat. 1966; 122: 742
   PubMed Web of Science ®Google Scholar
• Blachly P.H. Progress report on the methadone blockade treatment of heroin addicts in Portland. Northwest Med. 1970; 69: 172–76
   PubMedGoogle Scholar
• Blane G.H. Oxygen consumption in the new-born rat and the effects of maternally administered analgesics. Brit. J. Pharmacol. 1967; 30(3)478–87
   Google Scholar
• Blinick G. Menstrual function and pregnancy in narcotics addicts treated with methadone. Nature 1968; 219: 180
   PubMed Web of Science ®Google Scholar
• Blinick G., Wallach R.C., Jerez E. Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program. Amer. J. Obstet. & Gynec. 1969; 105(7)997–1003
   PubMedGoogle Scholar
• Bond J.M., et al. Irreversible corneal opacities produced in rats with high doses of dl-methadone HC1. Pharmacologist 1967; 9(2)231
   Google Scholar
• Bonnycastle D.D., Leonard C.S. An estimation of the activity of analgetic materials. J. Pharmacol. 1950; 100(2)14145
   Google Scholar
• Boyd E.M., Buell M. Methadone and respiratory tract fluid. Canad. Med. Assoc. J. 1950; 63(6)588–90
   PubMedGoogle Scholar
• Brill L., Jaffe J.H. The relevance of some newer American treatment approaches for England. Brit. J. Addict. 1967; 62: 375–86
   Google Scholar
• Broich J.R., De Mayo M.M., Dal Cortivo L.A. Separation and determination of opiates and diluents in illicit narcotic mixtures. J. Chromat. 1968; 33(3-4)526–29
   PubMedGoogle Scholar
• Buchel L., Levy J., Tanguy O. Enhancement of the analgesic action of l-methadone by 5-hydroxytryptamine. C. R. Acad. Sci. 1958; 246(20)2947–49
   Google Scholar
• Burks T.F., Long J.P. Release of gastrointestinal 5-hydroxytryptamine (5-HT) by morphine and related agents. Pharmacologist 1966; 8(2)216
   Google Scholar
• Burks T.F., Long J.P. Release of gastrointestinal 5-hydroxytryptamine by morphine and related agents. J. Pharmacol. Exper. Therap. 1967; 156(2)267–76
   PubMedGoogle Scholar
• Burks T.F., Long J.P. Responses of isolated dog small intestine to analgesic agents. J. Pharmacol. Exper. Therap. 1967; 158(2)264–71
   PubMedGoogle Scholar
• Casy A.F., Hassan M.M.A. Catalytic hydrogenolysis of benzylmethyl- amino analogs of methadone and a-methadol. J. Med. Chem. 1969; 12: 337–39
   PubMedGoogle Scholar
• Chappel C.I., Von Seemann C. Antitussive drugs. Progr. Med. Chem. 1963; 3: 89–145
   Google Scholar
• Chapple P.A.L., Gray G. One year's work at a centre for the treatment of addicted patients. Lancet 1968; 1(7458)908–11
   PubMedGoogle Scholar
• Chapple P.A.L., Gray G., Marks V. Treatment of heroin addiction. Lancet 1969; 1: 940, (May 3)
   PubMedGoogle Scholar
• Chen K.K. Pharmacology of methadone and related compounds. Ann. New York Acad. Sci. 1948; 51(1)83–97
   PubMedGoogle Scholar
• Chernov H.I., et al. Non-specificity of the mouse writhing test. Arch. Intern. Pharmacodyn. 1967; 167(1)171–78
   PubMedGoogle Scholar
• Cochin J. Analysis for narcotic analgesics and barbiturates in urine by thin-layer chromatographic techniques without previous extraction and concentration. Psychopharmacol. Service Center Bull. 1966; 3(4)53–60
   Google Scholar
• Cochin J., et al. Further observations on addiction of methadone in the monkey. Proc. Soc. Exper. Biol. Med. 1948; 69: 430
   PubMedGoogle Scholar
• Coen R.W., Light I.J., Sutherland J.M. Methadone substitution in neonatal narcotic withdrawal. Seventy-Ninth Annual Meeting, The American Pediatric Society. April 30 to May 3, 1969
   Google Scholar
• Collins R.J., Weeks J.R. Relative potency of codeine, methadone and dihydromorphinone to morphine in self-maintained addict rats. Arch. Exper. Pathol. Pharmacol. 1965; 249(6)509–14
   PubMedGoogle Scholar
• Collins R.J., Weeks J.R., Macgregor D.W. An attempt to demonstrate ceiling efficacy of analgesics in rats. Arch. Intern. Pharmacodyn. 1964; 147(1-2)76
   PubMedGoogle Scholar
• Cox B.M., Weinstock M. Quantitative studies of the antagonism by nalorphine of some of the actions of morphine-like analgesic drugs. Brit. J. Pharmacol. 1964; 22: 289–300
   Google Scholar
• Crema A., et al. The responses of the terminal bile duct to morphine and morphine-like drugs. J. Pharmacol. Exper. Therap. 1965; 149(3)373–78
   PubMedGoogle Scholar
• Cushman P., Bordier B., Hilton J.G. Hypothalmic-pituitary-adrenal axis in methadone-treated heroin addicts. J. Clin. Endocrinol. Metabol. 1970; 30: 24–29, (January)
   PubMedGoogle Scholar
• Deffenu G., Pegrassi L., Lumachi B. The use of Bradykinin-induced effects in rats as an assay for analgesic drugs. J. Pharm. Pharmacol. 1966; 18(2)135
   PubMedGoogle Scholar
• Denton J.E., Beecher H.E. New analgesics, II, and III. J.A.M.A. 1949; 141: 1146
   PubMed Web of Science ®Google Scholar
• Denton J.E., et al. A comparison of side-actions and analgesic effects of morphine, amidone, (4-4-diphenyl-6-diinethylarnino-heptanone-3) and its isomers in man. Fed. Proc. 1948; 7: 214
   PubMedGoogle Scholar
• Dole V.P. Thoughts on narcotics addiction. Bull. New York Acad. Sci. 1965; 41(2)211–13
   PubMedGoogle Scholar
• Dole V.P., Kim W.K., Eglitis I. Detection of narcotic drugs, tranquilizers, amphetamines, and barbiturates in urine. J.A.M.A. 1966; 198(4)349–52
   PubMed Web of Science ®Google Scholar
• Dole V.P., Kim W.K., Eglitis I. Extraction of narcotic drugs, tranquilizers, and barbiturates by cation-exchange paper and detection on a thin-layer chromatogram by a series of reagents. Psychopharmacol. Service Center Bull. 1966; 3(4)45–48
   Google Scholar
• Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. J.A.M.A. August 23, 1965; 193(8)646
   PubMed Web of Science ®Google Scholar
• Dole V.P., Nyswander M. Heroin addiction-A metabolic disease. Arch. Int. Med. 1967; 120: 19–24
   PubMed Web of Science ®Google Scholar
• Dole V.P., Nyswander M. Methadone maintenance and its implications for theories of narcotic addiction. Assoc. Res. Nerv. & Ment. Dis. 1966; 46: 359
   Google Scholar
• Dole V.P., Nyswander M. Rehabilitation of heroin addicts after blockade with methadone. New York State J. Med. August 1, 1966; 66: 2011
   PubMedGoogle Scholar
• Dole V.P., Nyswander M. Rehabilitation of the street addict. Arch. Environ. Health 1967; 14: 477–80
   PubMed Web of Science ®Google Scholar
• Dole V.P., Nyswander M. Study of methadone as an adjunct in rehabilitation of heroin addicts. Illinois Med. J. 1966; 130: 487–89
   Google Scholar
• Dole V.P., Nyswander M. The treatment of heroin addiction. J.A.M.A. 1966; 195: 972
   Google Scholar
• Dole V.P., Nyswander M. The use of methadone for narcotic blockade. Brit. J. Addict. 1968; 63: 55–57
   Google Scholar
• Dole V.P., Nyswander M., Kreek M.J. Narcotic blockade (original article). Arch. Int. Med. 1966; 118: 304–09
   PubMed Web of Science ®Google Scholar
• Dole V.P., Nyswander M., Kreek M.J. Narcotic blockade-A medical treatment for stopping heroin use by addicts. Tr. A. Am. Physicians 1966; 79: 122–35
   PubMedGoogle Scholar
• Dole V.P., Nyswander M., Warner A. Successful treatment of 750 criminal addicts. J.A.M.A. 1968; 206: 2708–11
   PubMed Web of Science ®Google Scholar
• Dole V.P., Warner A. Evaluation of narcotics treatment program. Amcr. J. Public Health 1967; 57(11)2000–08
   Google Scholar
• Dole V.P., et al. Methadone treatment of randomly selected criminal addicts. New England J. Med. 1969; 280: 1372–75
   PubMed Web of Science ®Google Scholar
• Dundee J.W., Clarke R.S.J., Loan W.B. Comparative toxicity of diamorphine, morphine, and methadone. Lancet July 29, 1967; 2: 7509
   Google Scholar
• Duvall H.J., Locke B.Z., Brill L. Follow-up study of narcotic drug addicts five years after hospitalization. Public Health Reports March, 1963; 78(3)185–93
   PubMed Web of Science ®Google Scholar
• Eadie G.S., Bernheim F., Fitzgerald D.B. The effect of methadon on the cholinesterase of the brain. Brit. J. Addict. 1968; 63: 55–57
   Google Scholar
• Eadie G.S., Bernheim F., Fitzgerald D.B. The inhibition of the cholinesterase of rat brain by methadon. J. Pharmacol. Exper. Thcrap. 1948; 94(1)19–21
   PubMedGoogle Scholar
• Easton N.R., Gardner J.H., Stevens J.R. A new synthesis and confirmation of the structure of amidone. J. Amer. Chem. Soc. 1947; 69(12)2941
   PubMedGoogle Scholar
• Easton N.R., et al. Some isomers of amidone and related compounds. J. Amer. Chem. Soc. 1948; 70: 76
   PubMedGoogle Scholar
• Eddy N.B. A new morphine-like analgesic. J. Amer. Pharm. Assoc. 1947; 8(11)536–40
   Google Scholar
• Eddy N.B. Newer narcotics. Amer. Prac. 1948; 3(l)37–42
   Google Scholar
• Eddy N.B. The use of drugs in the management of drug dependence. J. Tennessee Med. Assoc. 1967; 60: 269–73
   PubMedGoogle Scholar
• Eddy N.B., et al. Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanism, methodology and evaluation. Bull. Wld. Health Organ. 1969; 40(3)425–54
   PubMed Web of Science ®Google Scholar
• Eddy N.B., et al. Codeine and its alternates for pain and cough relief. 4. Potential alternates for cough relief. 5. Discussion and summary. Bull. Wld. Health Organ. 1969; 40(5)639–730
   PubMedGoogle Scholar
• Eddy N.B., et al. Drug dependence: Its significance and characteristics. Bull. Wld. Health Organ. 1965; 32: 721–33
   PubMed Web of Science ®Google Scholar
• Edwards G. Relevance of American experience of narcotic addiction to the British scene. Brit. Med. J. 1967; 3: 425–29
   PubMedGoogle Scholar
• Eisenbrandt L.L., Elliott H.W. Comparative in vivo and in vitro effects of methadone upon the QO2 of rat liver, kidney and jejunum. J. Pharmacol. Exper. Therap. 1949; 97(1)120–24
   PubMedGoogle Scholar
• Eisenbrandt L.L., et al. The role of the gastro-intestinal tract in the excretion of C14-labeled methadone by rats. J. Pharmacol. Exper. Thcrap. 1950; 98(2)200–05
   PubMedGoogle Scholar
• Elliot H.W., Abdel-Rahman M.A. Cardiovascular actions of narcotic analgesics. Amer. Heart J. 1965; 69: 567–68
   PubMedGoogle Scholar
• Elliot H.W., Elison C. Influence of some adrenal and pituitary hormones on the absorption and biological disposition of methadone. J. Pharmacol. Exper. Therap. 1961; 131(1)31–37
   PubMedGoogle Scholar
• Elliot H.W., Sutherland V.C. Influence of methadone on oxygen uptake and glycogenosis of rat liver slices. Proc. Soc. Exp. Biol. 1950; 75(1)242–44
   PubMedGoogle Scholar
• Elliot H.W., Warrens A.E., James H.P. Some effects of l-methyl-4-phenyl ethyl isonipecotate (Demerol) and 6-dimethylamino-4,4-diphenyl-3-heptanone (Amidone) upon the metabolism of rat brain tissue in vitro. J. Pharmacol. Exper. Therap. 1947; 91(2)98–102
   PubMedGoogle Scholar
• Elliott H.W., et al. Comparison of the nalorphine test and urinary analysis in the detection of narcotic use. Clin. Pharmacol. Therap. 1964; 5(4)405–13
   PubMedGoogle Scholar
• Elliott H.W., et al. The distribution of radioactivity in rats after administration of C14-labeled methadone. J. Pharmacol. Exper. Therap. 1949; 95(4)494–501
   PubMedGoogle Scholar
• Emmerson J.L., Anderson R.C. A method for the thin-layer chromato- graphy of analgesic drugs and related compounds in non-aqueous systems. J. Chromatog. 1965; 17: 495–500
   PubMedGoogle Scholar
• Ettinger M.J., Gero A. Interactions of narcotics and their antagonists with human serum esterase. Pharmacologist 1965; 7(2)164
   Google Scholar
• Ettinger M.J., Gero A. Interactions of narcotics and their antagonists with human serum esterase. I. Sites of action and nature of the inhibitory effect. II. Nature of the antagonism. Arch. Intern. Pharmacodyn. 1966; 164(1)96–119
   PubMedGoogle Scholar
• Everett F.G. The local anesthetic properties of amidone (Dolophine). Anesthesiology 1948; 9: 115
   PubMedGoogle Scholar
• Finnegan J.K., et al. Observations on the comparative pharmacologic actions of 6-dimethylamino-4,4-diphenyl-3-heptanone (amidone) and morphine. J. Pharm. Exper. Therap. 1948; 94: 269
   Google Scholar
• Fraser H.F., Grider J.A., jr. Treatment of drug addiction. Amer. J. Med. 1953; 14(5)571–77
   PubMed Web of Science ®Google Scholar
• Fraser H.F., et al. Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs, (B) A short-term “direct” addiction test. J. Pharmacol. Exper. Therap. 1961; 133(3)371–87
   PubMedGoogle Scholar
• Fraser HF., et al. Use of n-allylnormorphine in treatment of methadone poisoning in man. J.A.M.A. 1952; 148: 1205
   PubMed Web of Science ®Google Scholar
• Freedman A.M. Drug addiction: An eclectic view. J.A.M.A. 1966; 197: 878–82
   PubMed Web of Science ®Google Scholar
• Freedman A.M., et al. Cyclazocine and methadone in narcotic addiction. J.A.M.A. 1967; 202: 191–94
   PubMed Web of Science ®Google Scholar
• Frenkel M. Pijnbestrijding bij kanker. Ned. Tijdschr. Geneesk. 1968; 112(1)18–22
   PubMedGoogle Scholar
• Freymuth H.W. Methadone and the private practitioner. J. Med. Soc. New Jersey March, 1970; 67: 128–30
   PubMedGoogle Scholar
• Friend D.G. Accidental therapeutic drug addiction. Clin. Pharamacol. Therap. 1966; 7(6)832–34
   PubMedGoogle Scholar
• Gaarenstroom J.H. De keuze van een pijnstillend middel. Ned. Tijdschr. Geneesk. 1965; 109(14)64142
   Google Scholar
• Gadeke R. Evaluation of the central analgetic 6-dimethylamino-4; 4-diphenyl-3- heptanone ('methadone,' 'polamidone' etc.). Med. Mschr. 1952; 6(4)214–18
   PubMedGoogle Scholar
• Gasser G. Tierexperimentelle Untersuchunger ueber die Hamproduktion bei erhoehtem Druck in den ableitenden Harnwegen. Wien. Klin. Wschr. 1967; 79(16)289–94
   PubMedGoogle Scholar
• Gearing F.R., et al. Methadone maintenance treatment program, progress report of evaluation; submitted to New York State Narcotics Addiction Control Commission. March 31, 1970
   Google Scholar
• Geber W.F., Schramm L.C. Comparative teratogenicity of morphine, heroin and methadone in the hamster. Pharmacologist 1969; 11(2)248
   Google Scholar
• Genovese E., et al. Metodo per la Misurazione deH'Attivita' Analgesica nel Ratto.fiotf. Soc. Hal. Biol. Sper. 1968; 43(23)17, 19-23
   Google Scholar
• Gentling A.A., Lundy J.S. A new analgesic, AN-148. preliminary report. Proceedings of the Staff Meetings of the Mayo Clinic 1947; 22(13)249–51
   PubMedGoogle Scholar
• Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics Ed. 4. The Macmillan Company, New York 1970; 260
   Google Scholar
• Gordon N.B. Reaction-times of methadone treated ex-heroin addicts. Psycho- pharmacologia 1970; 16: 337–44
   PubMed Web of Science ®Google Scholar
• Greig M.E. The inhibition of hexokinase by amidone (2-dimethyl-amino-4,4-diphenylheptanone-5-hydrochloride). Arch. Biochem. 1948; 17: 129
   PubMedGoogle Scholar
• Greig M.E., Gibbons A.J. Action of some centrally acting drugs on ion transport in red cells. Science 1956; 123(3204)939–40
   PubMedGoogle Scholar
• Greig M.E., Howell R.S. The inhibition by amidone of pyruvate and succinate oxidation by rat brain and the reversal of the inhibition by boiled yeast extract. Arch. Biochem. 1948; 19(3)441–48
   PubMedGoogle Scholar
• Grumbach L., Chernov H.I. The analgesic effect of opiate-opiate antagonist combinations in the rat. J. Pharmacol. Exper. Therap. 1965; 149(3)385–96
   PubMedGoogle Scholar
• Guiffrida J.G., et al. Anesthetic management of drug abusers. Anesthesia Analg. 1970; 49: 272–78
   PubMed Web of Science ®Google Scholar
• Gunne L.M. Treatment of drug addiction with narcotic blockade. Lakartidningen 1966; 63: 4060–64
   PubMedGoogle Scholar
• Gupta G.N. Thin-layer chromatography in disposable plastic bags for radioactive and non-radioactive substances. J. Chromatog. 1969; 41(3-4)467–70
   Google Scholar
• Haag H.B., Finnegan J.K., Larson P.S. Pharmacologic observations of 1,1-diphenyl-1-(dimethyl-aminoisopropyl)-butanone-2. Fed. Proc. 1947; 6: 334
   PubMedGoogle Scholar
• Haas H. Comparative studies on analgesics. Arch. Exper. Path. Pharmak. 1950; 212(1-2)162–63
   PubMedGoogle Scholar
• Haas H. Vom Arzneimittel aus Pflanzen zum Synthetischen Arzneimittel. Med. Welt. 1967; 41: 2406–07
   Google Scholar
• Haas H., Hohagen E., Kollmannsperger G. Comparative study of analgesics. Arzneimittel-Forsch. 1953; 3(5)238–47
   PubMedGoogle Scholar
• Haensel R. Zur Pharmakologie des Schmerzes. Arch. Pharm. 1966; 299(2)40–41
   Google Scholar
• Haffner F. Experimentelle Prufung Schmerzstillender Mittel. Duetsche med. Wchnschr. 1929; 55: 731
   Google Scholar
• Haldane F.P. Systemic infections in heroin addicts. Lancet 1968; 1(7533)95
   Google Scholar
• Harder H.J., Leutner V. Morphin-Antagonisten, quantum et quando? Ueberdosierung ein Beitrag zur dosisgerechten und gezielten Antidot-behandlung. Anaesthesist 1966; 15(8)279–83
   PubMedGoogle Scholar
• Hawes A.J. Goodbye junkies. Lancet August 1, 1970; 2: 258
   PubMedGoogle Scholar
• Heaton A.M., Blumberg A.G. Thin-layer chromatographic detection of barbiturates, narcotics and amphetamines in urine of patients receiving psychotropic drugs. J. Chromatog. 1969; 41(3-4)367–70
   PubMedGoogle Scholar
• Hebb C.O., Konzett H. Difference between morphine and synthetic analgesics in their actions on ganglionic transmission. Nature 1949; 163(4149)720–21
   PubMedGoogle Scholar
• Helpern M., Rho Y. Deaths from narcotism in New York City. New York S. J. Med. 1966; 66(18)2391–2408
   PubMedGoogle Scholar
• Henderson F.G., Chen K.K. Effect of age upon toxicity of methadon. Proc. Soc. Exper. Biol. & Med. 1948; 68: 350
   Google Scholar
• Heroin and the new prescribers. Brit. Med. J. 1968; 1(5594)719–20
   PubMedGoogle Scholar
• Herr F., Perszasz J. A new method for the testing of analgetic effect. Arch. Exper. Pathol. 1950; 210(3)289–93
   PubMedGoogle Scholar
• Hildebrandt F., Matthay E. Action of the powerful analgetics amidone, amidone plus diphenylpiperidinoacetamide ('Polamivet') and 3-hydroxy-n-methylmorphinan on intestinal motility. Arch. Exper. Path. Pharmak. 1954; 221(5)399–403
   PubMedGoogle Scholar
• Hill H.E., et al. Comparative effects of methadone, meperidine and morphine on conditioned suppression. Arch. Intern. Pharmacodyn. 1966; 163(2)341–52
   Google Scholar
• Hoffman F. Drug addiction and logic. J.A.M.A. 1967; 201(6)491–92
   Google Scholar
• Hoffman L. A methadone program for addicts with chest disease. J.A.M.A. 1970; 211(6)977–82
   PubMedGoogle Scholar
• Hoffman L., et al. Methadone in the treatment of tuberculous heroin addicts. Clin Res. 1968; 16: 366
   Google Scholar
• Hoffmann G., Kempe D. Spasmolytic action of some analgesics on the smooth musculature of the intestine and blood vessels. Klin. Wschr. 1951; 29(19-20)349–51
   PubMedGoogle Scholar
• Hoppe J.O., Miller L.C. A comparison of the toxicity of methadon and some related compounds. Fed. Proc. 1948; 7: 228
   PubMedGoogle Scholar
• Hubach C.E., Jones F.T. Methadon hydrochloride. Optical properties, microchemical reactions, and X-ray diffraction data. Analyt. Chem. 1950; 22(4)595–98
   Google Scholar
• Hunter A.R., Pleuvry B.J., Rees J.M.H. The respiratory depressant effects of barbiturates and narcotic analgesics in the unanesthetized rabbit. Brit. J. Anaesth. 1968; 40(12)927–35
   PubMedGoogle Scholar
• Inturrisi C.E., Fujimoto J.M. The antidiuretic effect of narcotic analgesics in the mouse. Toxocol. Appl. Pharmacol. 1968; 13(2)251–57
   PubMedGoogle Scholar
• Irwin S., et al. The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. 1951; 101(2)132–43
   Google Scholar
• Is narcotic addiction a chronic disease?. J. Chron. Dis. 1966; 19: 949–51
   PubMedGoogle Scholar
• Isaac R.H., Nyswander M. Points raised on methadone. Amer. J. Psychiat. 1967; 124(4)570–71
   Google Scholar
• Isbell H. Management of self-identified codeine addict. JAMA 1969; 209(10)1533
   Google Scholar
• Isbell H., Vogel V.H. The addiction liability of methadon, (amidone, Dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome. Amer. J. Psychiat. 1949; 105: 909
   PubMed Web of Science ®Google Scholar
• Isbell H., et al. Effect of single doses of 10820 (4-4-diphenyl-6-dimethylamino- heptanone-3) on man. Fed. Proc. 1947; 6: 341
   PubMedGoogle Scholar
• Isbell H., et al. Experimental addiction to 10820 (44-diphenyl-6-dimethyl- amino-heptanone-3) in man. Fed. Proc 1947; 6: 264
   PubMedGoogle Scholar
• Isbell H., et al. Liability of addiction of 6-dimethyl-amino-4-4-diphenyl-3-heptanone (methadon, “amidone,” or “10820”) in man. Experimental addiction to methadone. Arch. Int. Med. 1948; 82: 362
   Google Scholar
• Isbell H., et al. The effects of single doses of 6-dimethylamino-4-4-diphenyl-3- heptanone (Amidone, methadone, or '10820') on human subjects. J. Pharmacol. Exper. Therap. 1948; 92: 83
   PubMedGoogle Scholar
• Isbell H., et al. Tolerance and addiction liability of 6-dimethylamino-4-4- diphenyl-heptanone-3 (methadone). JAM.A. 1947; 135: 888
   PubMed Web of Science ®Google Scholar
• Isbell H., et al. Treatment of the morphine abstinence syndrome with 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3). Fed. Proc. 1947; 6: 340
   PubMedGoogle Scholar
• Ishmael W.K., Stacy J.R. The use of Dolophine (dimethylamino heptanone-methadon) in the control of pain in bone and joint disorders. J. Oklahoma Med. Assoc. 1947; 40: 454
   PubMedGoogle Scholar
• Jaffe J.H., et al. Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. JAMA March 16, 1970; 211(11)1834
   PubMedGoogle Scholar
• Jaffe J.H., et al. Comparison of dl-alpha-acetyl methadol and methadone in the treatment of narcotics addicts. Pharmacologist 1969; 11(2)256
   Google Scholar
• Jaffe J.H., Kirkpatrick D. The use of ion-exchange resin impregnated paper in the detection of opiate alkaloids, amphetamines, phenothiazines and barbiturates in urine. Psychopharmacol. Service Center Bull. 1966; 3(4)49–52
   Google Scholar
• James H.P., Page E.W. Influence on some analgetics of obstetrical importance upon respiration of mature human placenta in vitro. Fed. Proc. 1948; 7: 230
   PubMedGoogle Scholar
• Jenney E.H., Pfeiffer C.C. Comparative analgesic and toxic effects of the optical isomers of methadon and isomethadon. Fed. Proc. 1948; 7: 231
   PubMedGoogle Scholar
• Johnson C.A., King R.E. A direct titrimetric method for the deter- mination of some organic bases in pharmaceutical preparations. J. Pharm. Pharmacol. 1963; 15: 584–88
   PubMedGoogle Scholar
• Karr N.W. Effects of 6-dimethylamino-4,4-diphenyl-3-heptanone (Dolophine) on intestinal motility. Fed. Proc. 1946; 6: 343
   Google Scholar
• Kirchhof A.C., David N.A. A clinical trial of a new synthetic heptanone analgesic (Dolophine). I. Preliminary Report. West. J. Surg. Obstet. & Gynec. 1947; 55: 183
   PubMedGoogle Scholar
• Kirchhof A.C., David N.A. Clinical trial of 6-dimethylamino-4,4-di-phenyl-3-heptanone (Dolophine) a synthetic analgesic. Fed. Proc. 1947; 6: 345
   Google Scholar
• Knoll J., Komlos E., Tardos L. Role of protein-binding in the synergism of analgetics and cholinergic agents. Acta Physiol. Acad. Sci. Hungary 1953; 4(1-2)131–40
   PubMedGoogle Scholar
• Konzett H., Bauer H. Zur Charakterisierung der Bradykinin-Wirkung auf dieglatte Muskulatur. Z. Physiol. Chem. 1968; 349(7)927–28
   PubMedGoogle Scholar
• Kuntze A. Neuroleptanalgesia. Vet. Rec. 1967; 80(8)278–80
   Google Scholar
• Kupferberg H.J., Burkhalter A., Way E.L. Fluorometric identification of sub-microgram amounts of morphine and related compounds on thin-layer chromatographs. J. Chromatog. 1964; 16: 558–59
   PubMedGoogle Scholar
• Lambert A., et al. Report of the Mayor's Committee on Drug Addiction to the Honorable R.C. Patterson, Jr., commissioner of Correction, New York City. Amer. J. Psychiat. November, 1930; 10(3)433–538
   Google Scholar
• Lapierre J. Possible hepatotoxic effect of methadone. Canad. Med. Assoc. Jr. 1969; 101: 113
   PubMed Web of Science ®Google Scholar
• Lasagna L. The clinical evaluation of morphine and its substitutes as analgesics. Pharmacol. Rev. March, 1964; 16: 47–83
   PubMedGoogle Scholar
• Leimdorfer A. An electroencephalographic analysis of the action of amidone, morphine, and strychnine on the central nervous system. Arch. Int. Pharmacodyn. 1948; 76: 153
   PubMedGoogle Scholar
• Leimdorfer A. Influence of amidone, morphine, and strychinine on the Straub-tail test of white mice. Fed. Proc. 1948; 7: 239
   PubMedGoogle Scholar
• Lewis J.R. The development of tolerance in rats to some new synthetic analgesics. J. Pharmacol. Exper. Therap. 1949; 96(1)31–37
   PubMedGoogle Scholar
• Loan W.B., Dundee J.W. The value of the study of postoperative pain in the assessment of analgesics. Brit. J. Anaesth. 1967; 39(9)743–50
   PubMedGoogle Scholar
• Longo V.G., Napolitano L. Action of analgesic drugs (morphine, meperidine, methadone) on rotatory nystagmus in the rabbit. J. Pharmacol. 1953; 107(2)154–59
   Google Scholar
• Lorenzetti O.J., Sancilio L.F. Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch. Intern. Pharmacodyn. 1970; 183: 391–402
   PubMedGoogle Scholar
• Lorenzetti O.J., Sancilio L.F. Usefulness of morphine addicted rats in estimating addiction liability. Pharmacologist 1966; 8(2)206
   Google Scholar
• Louria D.B. Medical complications associated with heroin use. Internal. J. Addict. 1967; 2(2)241–51
   Web of Science ®Google Scholar
• Louria D.B., Hensle T. The major medical complications of heroin addiction. Ann. Int. Med. 1967; 67(1)1–22
   PubMedGoogle Scholar
• Luckner H., Magun R. A method of quantitative testing of analgesic effects in naimal study. Z. ges. exp. Med. 1951; 117(2)133–45
   PubMedGoogle Scholar
• Luduena F.P., Ananenko E. The pharmacodynamic effects of some new analgesics. Arch. Internal, de Pharmacodyn. et Therap. 1950; 81(3)259–75
   Google Scholar
• Luduena F.P., et al. Some pharmacological actions of isomers of methadon. Fed. Proc. 1948; 7: 241
   PubMedGoogle Scholar
• Maddux J.F. Current approaches to the treatment of narcotic addiction. J. Nat. Med. Assoc. 1969; 69: 248
   Google Scholar
• Management of narcotic-drug dependence of high-dosage methadone HCl technique. Dole-Nyswander program. J.A.M.A. 1967; 201(12)956–57
   PubMedGoogle Scholar
• Mandy S., Ackerman A.B. Characteristic traumatic skin lesions in drug-induced coma. J.A.M.A. 1970; 213: 253–56
   PubMed Web of Science ®Google Scholar
• Marshall I., Weinstock M. A quantitative method for the assessment of physical dependence on narcotic analgesics in mice. Brit. J. Pharmacol. 1969; 37(2)505P–56P
   Google Scholar
• Matts S.G.F., Swan C.H.J., Wharton B.A. Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain. Postgrad. Med. J. 1964; 40: 103
   PubMedGoogle Scholar
• McCurley W.S., Tunnessen WW., Jr. Methadone toxicity in a child. Pediatrics 1969; 43(1)90–92
   PubMedGoogle Scholar
• McMahon R.E., Culp H.W., Marshall F.J. The metabolism of a-dl-acetylmethadol in the rat: The identification of the probable active metabolite. J. Pharm. Exper. Therap. 1965; 149: 436
   PubMed Web of Science ®Google Scholar
• McMartin C., Simpson P., Thorpe N. The specific assay of basic drugs in urine by CM-cellulose chromatography using continuous drug-dye complex extraction as a detection system. J. Chromatog. 1969; 43(1)72–83
   PubMedGoogle Scholar
• Medical treatment of addiction. New York Acad. Sci. 1969; 9: 11
   Google Scholar
• Merry J. Assessing heroin addiction. Lancet 1968; 1(7536)244
   Google Scholar
• Methadone clinical trials under study. J.A.M.A. April 14, 1969; 208(2)251–52
   Google Scholar
• Methadone in the management of opiate addiction. Medical Letter November 28, 1969; 11(24)97
   Google Scholar
• Methadone maintenance for heroin addiction. Yale Law J. 1969; 78: 1175–1211
   Web of Science ®Google Scholar
• Methadone management of heroin addiction. Bull. New York Acad. Med. June, 1970; 46: 391–95
   PubMedGoogle Scholar
• Methadone replacement on the way?. J.A.M.A. September 15, 1969; 209(10)1627
   Google Scholar
• Methadone treatment of randomly selected criminal addicts. New England J. Med. 1969; 280(25)1372–75
   PubMed Web of Science ®Google Scholar
• Miller J.W., Elliott H.W. In vitro studies on the diphasic action of methadone. J. Pharmacol. Exper. Therap. 1954; 110: 106–14
   PubMedGoogle Scholar
• Miller J.W., Elliott H.W. Rat tissue levels of carbon-14 labeled analgetics as related to pharmacological activity. J. Pharmacol. 1955; 113(3)283–91
   Google Scholar
• Milosevic M.P. The analgesic activity of sympathomimetic amines. Acta. Med. Iugosl. 1958; 12(1-2)111–19
   Google Scholar
• Milosevic M.P. The effect of sympathomimetic amines on pain sensitivity. Acta. Med. Iugoslav. 1956; 10(3)280–88
   PubMedGoogle Scholar
• Monitoring the mainliner. Lab. Manag. August, 1969; 7: 30–31
   Google Scholar
• Molinengo L., Ricci-Gamalero S. Action of codeine, pethidine, and methadone on the operant behavior of the rat. Psychopharmacologia 1970; 17: 34–48
   PubMedGoogle Scholar
• Montalvo J.G., et al. Identification of drugs of abuse in urine. J. Chromatog. 1970; 47: 542–45
   PubMedGoogle Scholar
• Myerson D.J. Methadone treatment of addicts. New England J Med. August 14, 1969; 281: 390–91
   PubMedGoogle Scholar
• Nahum L.H. The methadone treatment for the criminal addict. Connecticut Med. J. August, 1969; 33: 504
   Google Scholar
• Narcotics and medical practice—medical use of morphine and morphine-like drugs and management of persons dependent on them. J.A.M.A. 1967; 202: 209–12
   PubMedGoogle Scholar
• Van Der Nat J. Hyperpyrexie tijdens narcose. Ned. Tijdschr. Geneesk. 1968; 112(49)2227–29
   PubMedGoogle Scholar
• Nelson A.S. Medical problems associated with addiction to opioid drugs. Internat. J. Addict. 1966; 1: 50–61
   Web of Science ®Google Scholar
• Neudek K. Entziehungsprogramm fuer Rauschgiftsuechtige in den USA. Muench. Med. Wochenschr. 1970; 112(22)1054–56
   PubMedGoogle Scholar
• Nilsson E. On treatment of barbiturate poisoning. Acta Med. Scandinav. 1951; 140(Supplement)1
   PubMedGoogle Scholar
• Nix J.T. Control program for heroin addiction. J.A.M.A. February 23, 1970; 211: 1378
   Google Scholar
• Nix J.T. Methadone for narcotics addicts. J.A.M.A. March 31, 1969; 207: 2439
   PubMedGoogle Scholar
• Noirfalise A., Mees G. Chromatographic sur couche mince de quelques alcaloides et bases aminees.7. Chromatog. 1967; 31(2)594–97
   Google Scholar
• Nyswander M. From drug addict to patient. NYSDB Bull 1967; 5, (June)
   Google Scholar
• Nyswander M., Dole V.P. The present status of methadone blockade treatment. Amer. J. Psychiat. 1967; 123(11)1441–42
   PubMedGoogle Scholar
• O'Donnell J.A. A follow-up of narcotics addicts. Amer. J. Orthopsychiatry October, 1964; 34(4)948–54
   PubMedGoogle Scholar
• Ofner P., Walton E. Search for new analgesics. IV. Variations in the basic side-chain of amidone. J. Chem. Soc. 1950; 2158–2166, (1975-2257)
   Google Scholar
• Ono M., Engelke B.F., Fulton C. Procedures for assured identification of morphine, dihydromorphinone, codeine, norcodeine, methadone, quinine, methamphetamine, etc., IN human urine. Bull. Stupefiants 1969; 21(2)31–40
   Google Scholar
• Orahovats P.D., Lehman E.G., Chapin E.W. Potentiating effects of quinine. I. Analgesics and hypnotics. Arch. Int. Pharmacodyn. 1957; 110(2-3)245–58
   PubMedGoogle Scholar
• Palosi E., Szporny L. New, simple method for the informative investigation of sedatives. Psychopharmacologia 1967; 12(1)44–49
   PubMedGoogle Scholar
• Parbrook G.D. Post-operative pain relief: Comparison of methadone and morphine when used concurrently with nitrous-oxide analgesia. Brit. Med. J. 1966; 2(5514)616–18
   PubMedGoogle Scholar
• Parker K.D., Hine C.H. Manual for the determination of narcotics and dangerous drugs in the urine. Psychopharmacol. Service Center Bull. 1966; 3(3)18–42
   Google Scholar
• Parker K.D., et al. Urine screening techniques employed in the detection of users of narcotics and their correlation with the nalorphine test. J. Forensic Sci. 1966; 11: 152–66
   PubMedGoogle Scholar
• Paulus I., Halliday R. Rehabilitation and the narcotic addict: Results of a comparative methadone withdrawal program. Canad. Med. Assoc. J. 1967; 96: 655
   PubMed Web of Science ®Google Scholar
• Pearl J., Aceto M.D., Harris L.S. Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. J. Pharmacol. Exper. Therap. 1968; 160(1)217–30
   PubMedGoogle Scholar
• Perkins M.E., Bloch H.I. A study of some failures in methadone treatment; presented at the 123rd annual meeting of the American Psychiatric Association, San Francisco, California, May 11-15, 1970
   Google Scholar
• Perkins M.E., Bloch H.I. Survey of methadone maintenance treatment program. Amer. J. Psychiat. April, 1970; 125: 1389–96
   Google Scholar
• Pfeiffer C.C., et al. Experimental methods for studying analgesia. Ann. New York Acad. Sci. 1948; 51(1)21–33
   PubMedGoogle Scholar
• Pfeiffer C.C., Santos-Martinez J., Sherrod T.R. The nature of the prosthetic groups of analgesics and their possible action as blocking agents. Fed. Proc. 1948; 7: 248
   Google Scholar
• Phatak N.M., David N.A. Addiction potentialities of some methadone analgesics and alpha-acetyl-methadol as determined by their hyperglycemic responses in rabbits. Curr. Res. Anesth. 1953; 32(4)242–49
   PubMedGoogle Scholar
• Pohland A., Marshall F.J., Carney T.P. Optically active com- pounds related to methadon.J. Med. Chem. 1949; 71: 460
   Google Scholar
• Popkin R.J. Experiences with a new synthetic analgesic, Amidone: Its action on ischemic pains of occlusive arterial disease. Amer. Heart J. 1948; 35: 793
   PubMedGoogle Scholar
• Portoghese P.S. Stereochemical factors and receptor interactions associated with narcotic analgesics. J. Pharm. Sci. 1966; 55(9)865
   PubMedGoogle Scholar
• Portoghese P.S., Williams D.A. Stereochemical studies on medicinal agents. VII. Absolute stereochemistry of methadol isomers and the role of the 6-methyl group in analgetic activity. J. Med. Chem. 1969; 12: 839–44
   PubMedGoogle Scholar
• Portoghese P.S., Williams D.A. Stereochemistry of methadol diaster- eomers. J. Pharm. Sci. 1966; 55: 990–01
   PubMedGoogle Scholar
• Powell C.E., Chen K.K. Action of Dolophine on the animal uterus. J. Amer. Pharm. Assoc. 1948; 37: 516
   Google Scholar
• Powers B.R. Use of methadone to combat withdrawal symptoms of “Dilaudid” addiction: Case report. J. Tennessee Med. Assoc. 1949; 42: 83
   Google Scholar
• Progress report of evaluation of methadone maintenance treatment program as of March 31, 1968. J.A.M.A. 1968; 206: 2712–14
   PubMed Web of Science ®Google Scholar
• Quijada L., Contreras E., Tamayo L. Antagonistic action of tolazoline upon the analgesic effect of some morphine analogues. Med. Exp. 1967; 16(3)190–92
   Google Scholar
• Raskin H.A. Rehabilitation of the narcotic addict. J.A.M.A. September 12, 1964; 189(12)180–82
   Google Scholar
• Remy D., Wolsky H. Effect of methadone, in comparison with that of morphine and of isonipecaine, on ventilation capacity with carbon dioxide breathing. Therapie der Gegenwart 1950; 2: 41–46
   Google Scholar
• Rice J., Cohen L. Narcotic drug addiction: One year's experiences at Pilgrim State Hospital. Psychiat. Quart. July, 1965; 39: 457–65
   PubMed Web of Science ®Google Scholar
• Rickards J.C., et al. Studies on the distribution and metabolism of methadone in normal and tolerant rats by a new colorimetric method. J. Pharmacol. Exper. Therap. 1950; 98: 380–91
   PubMed Web of Science ®Google Scholar
• Roubicek J., Zaks A., Freedman A.M. EEG changes produced by heroin and methadone. Electroenceph. Clin. Neurophysiol. 1969; 27: 667
   PubMedGoogle Scholar
• Roxburgh R.C., Munro-Faure D. Amidone overdosage in a child. Lancet 1951; 1: 174
   Google Scholar
• Ruemmler R., Haller R. Chromatographic methods for the separation of methadone and its reduction products, α- and β-methadol. Arzneim. Forsch. 1970; 20: 281–82
   PubMedGoogle Scholar
• Sander M. Chemistry and analgetic activity of basic l:l-diphenylalkane derivatives. Arzneim. Forsch. 1954; 4(3)183–89, 4(4):257;4(6):375-80
   PubMedGoogle Scholar
• Sapira J.D., et al. Addiction to methadone among patients at Lexington and Fort Worth. Public Health Reports August, 1968; 83(8)691–94
   PubMedGoogle Scholar
• Schaumann O., Lindner E. New synthetic compounds of the “polamidone series” with anticholinergic action. Arch. Exp. Path. U. Pharmakol. 1951; 211(1)93–102
   Google Scholar
• Schaumann W. Effects of morphine-like analgetics on the guinea-pig ileum in situ. Arch. Exp. Path. U. Pharmakol. 1954; 223(4)348–54
   PubMedGoogle Scholar
• Schneider K.W. Behandlung des Herzinfarktes in der Praxis (Soforttherapie und Langzeitbehandlung). Med. Klin. 1966; 61(41)1616
   Google Scholar
• Schneider K.W. Klinik und Therapie der Koronarinsuffizienz. Med. Mschr. 1967; 21(10)439–43
   PubMedGoogle Scholar
• Schneider K.W. Behandlung des Herzinfarktes in der Praxis Soforttherapie und Langzeitbehandlung. Therapiewoche 1967; 17(13)396403
   Google Scholar
• Schoolar J.C., Idanpaan H.P., Keats A.S. Pentazocine addiction. Lancet 1969; 1(7608)1263
   PubMedGoogle Scholar
• Schueller F.W., Gross E.G. Effect of two new analgetic agents on the oxygen consumption of brain in vitro. Proc. Soc. Exp. Biol. Med. 1948; 69(3)566–60
   PubMedGoogle Scholar
• Scott C.C., Chen K.K. The action of 1,1-diphenyl-1-(dimethylaminoiso-propyl)-butanone-2, a potent analgesic agent. J. Pharmacol. Exper. Therap. 1946; 87: 63
   PubMedGoogle Scholar
• Scott C.C., Kohlstaedt K.G., Chen K.K. Comparison of the pharmacologic properties of some new analgesic substances. Anesth. & Analg. 1947; 26: 12
   Google Scholar
• Scott C.C., Robbins E.B., Chen K.K. Pharmacologic comparison of the optical isomers of methadon. J. Pharmacol. Exper. Therap. 1948; 93: 282
   PubMed Web of Science ®Google Scholar
• Scott C.C., et al. Further observations on the pharmacology of Dolophine. Fed. Proc. 1947; 6: 370
   PubMedGoogle Scholar
• Scott M.E., Orr R. Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute mycardial infarction. Lancet 1969; 1(7605)1065–67
   PubMed Web of Science ®Google Scholar
• Scott W.W., et al. Early clinical experience with Dolophine (No. 10820). Anesth. & Analg. 1947; 26: 18
   Google Scholar
• Seevers M.H. Animal experimentation in studying addiction to the newer synthetic analgesics. Ann. New York Acad. Sci. 1948; 51(1)98–107
   PubMedGoogle Scholar
• Shamoian C.A., Shapiro A.K. Abuse of an euphoretic combination. J.A.M.A. 1969; 207(10)1919
   PubMedGoogle Scholar
• Shemano I., Wendel H. A rapid screening test for potential addiction liability of new analgesic agents. Toxicol. & Appl. Pharm. 1964; 6: 334
   PubMed Web of Science ®Google Scholar
• Sherrod T.R., et al. Methadone derivatives of pharmacological interest. Fed. Proc. 1948; 7: 255
   PubMedGoogle Scholar
• Shideman F.E., Johnson H.T. Acute vascular tolerance to morphine, Demerol, and 1,1-diphenyl-1-(dimetliylamino-isopropyl)butanone-2 (amidone) in the dog. Fed. Proc. 1948; 7: 371
   Google Scholar
• Shideman F.E., Johnson H.T. Acute vascular tolerance to morphine, isonipecaine (Demerol) and methadon (amidone) in the dog. J. Pharmacol. Exper. Therap. 1948; 92(4)414–20
   PubMedGoogle Scholar
• Simionovici M., Winter D. L'antagonisme de la morphine a legard de certains phenomenes centraux reserpiniques. Therapie 1964; 19(4)991–95
   PubMedGoogle Scholar
• Sinitsin L.N. Effect of morphine and other analgesics on brain evoked potentials. Int. J. Neuropharmacol. 1964; 3(3)321–26
   PubMedGoogle Scholar
• Smith A.A., Karmin M., Gavitt J. Tolerance to the lenticular effects of opiates. J. Pharmacol. Exper. Therap. 1967; 156(1)85–91
   PubMedGoogle Scholar
• Smith C.C., Lehman E.G. Analgesics. I. Effects of analgesic combinations on reaction time in rats. J. Pharmacol. 1953; 108(3)336–39
   Google Scholar
• Smits S.E., Takemori A.E. Quantitative studies on the antagonism by naloxone of some narcotic and narcotic-antagonist analgesics. Brit. J. Pharmacol. July, 1970; 39: 627–38
   PubMedGoogle Scholar
• Smits S.E., Takemori A.E. Studies on the anti-writhing analgesic receptors in mice. Pharmacologist 1969; 11(2)257
   Google Scholar
• Sollmann T. A Manual of Pharmacology and Its Application to Therapeutics and Toxicology Eighth edition. W.B. Saunders Company, Philadelphia 1964; 282–283
   Google Scholar
• Stern R. The pregnant addict. Amer. J. Obstet. & Gynec. 1966; 994(2)253
   Google Scholar
• Sung C., Way E.L. The effect of the liver on the metabolism of d,l-methadone in vitro and in vivo. J. Pharmacol. Exper. Therap. 1950; 98(1)72
   PubMedGoogle Scholar
• Swerdlow M. General analgesics used in pain relief: Pharmacology. Brit. J. Anaesth. 1967; 39(9)699–712
   PubMedGoogle Scholar
• TLC: Growing clinical use. Lab. Management July, 1969; 7: 27
   Google Scholar
• Taber R.I., et al. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice. J. Pharmacol. Exper. Therap. 1969; 169(1)29–38
   PubMedGoogle Scholar
• Taber R.I., Greenhouse D.D., Irwin S. Interactions between narcotic- analgesics, antagonists and other drugs on chemically-induced writhing in mice. Pharmacologist 1965; 7(2)164
   Google Scholar
• Tainter M.L., Buchanan O.H. A comparison of certain actions of Demerol and methadone. California Med. 1949; 70(1)35–43
   PubMedGoogle Scholar
• Takemori A.E. Cross-cellular adaptation to methadone and meperidine in cerebral cortical slices from morphinized rats. J. Pharmacol. Exper. Therap. 1962; 135(2)252–55
   PubMedGoogle Scholar
• Tarlington M.J.K. Peritoneal dialysis in a country district hospital. Med. J. Austr. 1969; 1(25)1293–96
   PubMedGoogle Scholar
• Tenen S.S. Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychophannacologia 1968; 12(4)278–85
   PubMedGoogle Scholar
• Thompson W.J., Walton R.P. Elevation of plasma histamine levels in the dog following administration of muscle relaxants, opiates, and macromolecular polymers. J. Pharmacol. Exper. Therap. 1964; 143: 131
   PubMed Web of Science ®Google Scholar
• Thorp R.H. The pharmacology of the optical isomers of amidone (2-dimethyl-amino-4 : 4-diphenylheptan-5-one). Brit. J. Pharmacol. & Chemo. 1949; 4(1)98–104
   PubMedGoogle Scholar
• Thorp R.H., et al. Optical isomers of amidone with a note on isoamidone. Nature 1947; 160–605
   PubMedGoogle Scholar
• Tomlinson K.A., Kay P.G. Methadone hydrochloride (Physeptone)-a case of idiosyncrasy. Brit. Med. J. 1966; 2(5520)1007
   Google Scholar
• Troxil E.B. Clinical evaluation of the analgesic methadon. J.A.M.A. 1948; 135: 920
   Google Scholar
• Uchiyama J., Kirchhof A.C., David N.A. Spasmolytic action of Dolophine. Proc. Soc. Exper. Biol. & Med. 1947; 66: 417
   PubMedGoogle Scholar
• Vallve C. Die Wirkung von Spasmolytica auf die mechanische und elektrische Aktivitaet des isolierten Rattenuterus. Arzneim. Forsch. 1967; 17(7)882–85
   PubMedGoogle Scholar
• Van Sloten M., Kinohi R.G., Irwin S. Drug effects on the foot shock-induced behavior of paired mice. West. Pharmacol. Soc. 1968; 11: 46
   PubMedGoogle Scholar
• Veatch R.M., Adler T.K., Way E.L. The importance of steric configuration in certain morphinemimetic actions of synthetic analgetics. J. Pharmacol. Exper. Therap. 1964; 145(1)11–19
   PubMedGoogle Scholar
• Vessman J. Gas chromatography of high-boiling amines. Acta Pharm. Succica 1964; 1: 183
   PubMedGoogle Scholar
• Vogel V.H. The treatment of drug addiction. J.A.M.A. November 8, 1965; 194(6)210
   Google Scholar
• Vollum D.I. Skin lesions in drug addicts. Brit. Med. J. June 13, 1970; 1: 647
   PubMedGoogle Scholar
• Wallach B.C., Jerez E., Blinick G. Pregnancy and menstural function in narcotics addicts treated with methadone. The methadone maintenance treatment program. Amer. J. Obstet. & Gynec. 1969; 105(8)1226–29
   PubMedGoogle Scholar
• Wallenstein S.L., Beaver W.T., Houde R.W. Clinical analgesic studies of methadone utilizing both complete and incomplete block crossover designs. Pharmacologist 1966; 8(2)207
   Google Scholar
• Walter A.J. Possible hepatotoxic effect of methadone. Canad. Med. Assoc. J. 1969; 100: 265
   PubMed Web of Science ®Google Scholar
• Way E.L. Detection of narcotic usage by the pupillary method. Psychopharmacol. Service Center Bull. 1966; 3(4)61–62
   Google Scholar
• Way E.L., Adler T.K. The pharmacologic implications of the fate of morphine and its surrogates. Pharmac. Rev. edition 12. 1960; 383–446
   Google Scholar
• Way EX., Sung C.Y., McKelway W.P. The absorption, distribution and excretion of d l methadone. J. Pharmacol. Exper. Therap. 1949; 97(2)222–28
   PubMedGoogle Scholar
• Weinstock M. The role of the sympathetic nervous system in mediating the action of analgesic drugs on the lens. Arch. Pharmakol. Exp. Pathol. 1968; 259(2)201–02
   PubMedGoogle Scholar
• Weinstock M., Marshall A.S. The influence of the sympathetic nervous system of the action of drugs on the lens. J. Pharmacol. Exper. Therap. 1969; 166(1)8–13
   PubMedGoogle Scholar
• Whitman G.B. Man Alive is alive and well. John Hopkins Hospital Alumnae Magazine 1970; 69(1)8
   Google Scholar
• Wieland W.F., Chambers C.D. Methadone maintenance: A comparison of two stabilization techniques. Internat. J. Addict. 1970; 5(4)645–660
   PubMed Web of Science ®Google Scholar
• Wieland W.F. Methadone maintenance treatment of chronic narcotic addiction. New Physician 1969; 18: 210–11
   Google Scholar
• Wikler A., Altschul S. Effects of methadone and morphine on the electroencephalogram of the dog. J. Pharmacol. 1950; 98(4)437–46
   Google Scholar
• Wikler A., Frank K. Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadon. J. Pharmacol. Exper. Therap. 1948; 94: 4, 382
   Google Scholar
• Wikler A., Frank K. Tolerance and physical dependence in intact and chronic spinal dogs during addiction to 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3). Fed. Proc. 1947; 6: 382
   Google Scholar
• Williams E.M.V., Streeten D.H.P. The action of morphine, pethidine and amidone upon the intestinal motility of conscious dogs. Brit. J. Pharmacol. 1950; 5(4)584–603
   Google Scholar
• Williams H.R., Moy W., Johnston W. Low and high methadone maintenance in out-patient treatment of the heroin addict. Internal. J. Addict. 1970; 5(4)637–644
   PubMed Web of Science ®Google Scholar
• Woods L.A., Wyngaarden J.B., Seevers M.H. Addiction potential- ities of 1,1-diphenyl-1-(-dimethylamino-propyl)-butanone-2 hydrochloride (Amidone) in the monkey. Proc Soc. Exper. Biol. Med. 1947; 65(1)113–14
   PubMedGoogle Scholar
• Woods L.A., et al. The addiction potentialities of l,l-diphenyl-l-(dimethyl- aminoisopropyl)-butanone-2(amidone) in the monkey. Fed. Proc. 1947; 7: 387
   Google Scholar
• World Health Organization. Technical Report Series No. 343, 1966; 9, (Section 6)
   Google Scholar
• World Health Organization Expert Committee on Dependence-Producing Drugs. Bull. Narcotics January-March, 1967; 19(1)29–32, Fifteenth Report
   Google Scholar
• world Health Organization Expert Committee on Drug Dependence. Technical Report Series No. 407, 1969; 1–28
   Google Scholar
• Zaks A.M., et al. Intravenous diacetylmorphine (heroin) in studies of opiate dependence. Dis. Nerv. Syst. 1969; 30(Supplement 2)89–92
   PubMedGoogle Scholar